Breast Cancer Research - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

Breast Cancer Research

ISSN Print: 1465-5411

ISSN Online:

主页: http://breast-cancer-research.com

分享:

Molecular response to aromatase inhibitor treatment in primary breast cancer

Alan Mackay, Ander Urruticoechea, J Michael Dixon, Tim Dexter, Kerry Fenwick, Alan Ashworth, Suzanne Drury, Alexey Larionov, Oliver Young, Sharon White, William R Miller, Dean B Evans, Mitch Dowsett

Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis

Todd M Savarese, William C Strohsnitter, Hoi Low, Qin Liu, Inkyung Baik, William Okulicz, David P Chelmow, Pagona Lagiou, Peter J Quesenberry, Kenneth L Noller, Chung-Cheng Hsieh

HER-2 therapy. HER-2/neu diagnostics in breast cancer

Walter P Carney, Kim Leitzel, Suhail Ali, Rainer Neumann, Allan Lipton

Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment

Guadalupe Montero Girard, Silvia I Vanzulli, Juan Cerliani, María Bottino, Julieta Bolado, Jorge Vela, Damasia Becu-Villalobos, Fernando Benavides, Silvio Gutkind, Vyomesh Patel, Alfredo Molinolo, Claudia Lanari

SirT1 modulates the estrogen–insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice

Hongzhe Li, Grace K Rajendran, Ninning Liu, Carol Ware, Brian P Rubin, Yansong Gu

A personal viewpoint against the motion that breast cancer patient advocacy groups unfairly distort the cancer budget

Emma L Pennery

IGFBP3 mRNA expression in benign and malignant breast tumors

Zefang Ren, Aesun Shin, Qiuyin Cai, Xiao-Ou Shu, Yu-Tang Gao, Wei Zheng

Psychosocial controversies in breast cancer

Lesley Fallowfield

Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls

Imogen Locke, Zsofia Kote-Jarai, Mary Jo Fackler, Elizabeth Bancroft, Peter Osin, Ashutosh Nerurkar, Louise Izatt, Gabriella Pichert, Gerald PH Gui, Rosalind A Eeles

Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer

Lesley Fallowfield

Is breast cancer advocacy distorting the cancer budget to the disadvantage of other tumours?

Jim Cassidy

Roles for estrogen and progesterone in breast cancer prevention

D Joseph Jerry

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

Ahmedin Jemal, Elizabeth Ward, Michael J Thun

Is breast cancer prognosis inherited?

Mikael Hartman, Linda Lindstr？m, Paul W Dickman, Hans-Olov Adami, Per Hall, Kamila Czene

Tumour dormancy in breast cancer: an update

Muriel Brackstone, Jason L Townson, Ann F Chambers

Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome

Vincent Vuaroqueaux, Patrick Urban, Martin Labuhn, Mauro Delorenzi, Pratyaksha Wirapati, Christopher C Benz, Renata Flury, Holger Dieterich, Frédérique Spyratos, Urs Eppenberger, Serenella Eppenberger-Castori

Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?

Margaret A Shupnik

Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients

Tatsuya Toyama, Zhenhuan Zhang, Mariko Nishio, Maho Hamaguchi, Naoto Kondo, Hirotaka Iwase, Hiroji Iwata, Satoru Takahashi, Hiroko Yamashita, Yoshitaka Fujii

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)

Georgia Chenevix-Trench, Roger L Milne, Antonis C Antoniou, Fergus J Couch, Douglas F Easton, David E Goldgar, CIMBA

Identification of women with an increased risk of developing radiation-induced breast cancer

Elisabeth Cardis, Janet Hall, Sean V Tavtigian

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

Yunpeng Su, Kathryn Vanderlaag, Courtney Ireland, Janelle Ortiz, Henry Grage, Stephen Safe, Arthur E Frankel

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer

Anita Langer？d, Hongjuan Zhao, ？rnulf Borgan, Jahn M Nesland, Ida RK Bukholm, Tone Ikdahl, Rolf K？resen, Anne-Lise B？rresen-Dale, Stefanie S Jeffrey

An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells

Stephan Duss, Sylvie André, Anne-Laure Nicoulaz, Maryse Fiche, Hervé Bonnefoi, Cathrin Brisken, Richard D Iggo

Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer

Qamar J Khan, Bruce F Kimler, Anne P O'Dea, Carola M Zalles, Priyanka Sharma, Carol J Fabian

Neoadjuvant endocrine therapy: clinical and biological issues

IE Smith

Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2

Claire E Lewis, Russell Hughes

HER2 gene status in primary breast cancers and matched distant metastases

Coya Tapia, Spasenija Savic, Urs Wagner, René Sch？negg, Hedvika Novotny, Bruno Grilli, Michelle Herzog, Audrey Barascud, Inti Zlobec, Gieri Cathomas, Luigi Terracciano, Georg Feichter, Lukas Bubendorf

Chemotherapy in metastatic disease: an overview

IE Smith

Gata-3 and mammary cell fate

Matthew J Naylor, Christopher J Ormandy

Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine

Lance D Miller, Edison T Liu

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study

Annegien Broeks, Linde M Braaf, Angelina Huseinovic, Anke Nooijen, Jos Urbanus, Frans BL Hogervorst, Marjanka K Schmidt, Jan GM Klijn, Nicola S Russell, Flora E Van Leeuwen, Laura J Van 't Veer

Correction: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

Elisabetta Munzone, Giuseppe Curigliano, Andrea Rocca, Giuseppina Bonizzi, Giuseppe Renne, Aron Goldhirsch, Franco Nolè

Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: Relation to tumor phenotype and clinical outcome

Eleni Mylona, Christina Magkou, Ioanna Giannopoulou, George Agrogiannis, Sofia Markaki, Antonios Keramopoulos, Lydia Nakopoulou

Recent translational research: circulating tumor cells in breast cancer patients

Volkmar Müller, Daniel F Hayes, Klaus Pantel

Wide local excision of breast carcinomas: the effect of ultrasound and wire guidance on the Surgical Precision Index

NPM Jain, CLE Osborne, CS Holgate, JR Steel, PA Jones, RM Watkins

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer

Valgerdur Birgisdottir, Olafur A Stefansson, Sigridur K Bodvarsdottir, Holmfridur Hilmarsdottir, Jon G Jonasson, Jorunn E Eyfjord

Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8+ T cells by dendritic cells loaded with killed allogeneic breast cancer cells

Hiroaki Saito, Peter Dubsky, Carole Dantin, Olivera J Finn, Jacques Banchereau, A Karolina Palucka

The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells

Ma'anit Shapira, Eli Kakiashvili, Tzur Rosenberg, Dan D Hershko

Translating breast cancer research into clinical practice — new approaches and better outcomes

SRD Johnston

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer

WR Miller

Chromosome translocations may play a significant role in breast cancer

KL Howarth, KA Blood, JC Pole, SL Cooke, Y-L Chua, JC Beavis, B-L Ng, PAW Edwards

Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer

Nigel PS Crawford, Argyrios Ziogas, David J Peel, James Hess, Hoda Anton-Culver, Kent W Hunter

The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis

Bernard Têtu, Jacques Brisson, Chang Wang, Hélène Lapointe, Geneviève Beaudry, Caty Blanchette, Dominique Trudel

Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort

Eric J Jacobs, Heather Feigelson, Elizabeth B Bain, Kerri A Brady, Carmen Rodriguez, Victoria L Stevens, Alpa V Patel, Michael J Thun, Eugenia E Calle

Correction: Increased copy number at 3p14 in breast cancer

Ingrid Ljuslinder, Beatrice Malmer, Irina Golovleva, Marcus Thomasson, Kjell Grankvist, Thomas H？ckenstr？m, Stefan Emdin, Yvonne Jonsson, H？kan Hedman, Roger Henriksson

Correction: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Trevor Powles, Alexander Paterson, Eugene McCloskey, Phil Schein, Bobbi Scheffler, Alwynne Tidy, Sue Ashley, Ian Smith, Lars Ottestad, John Kanis

Bone versus breast density

Jack Cuzick

Promoting early breast cancer presentation in women after their final routine breast screening mammogram

A Ramirez

The Dutch experience of digital mammography in screening

R van Engen

Investigating the role of Wnt signalling in lobuloalveolar development of the mammary gland

RJ Evans, C Dale

©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705